medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 6

<< Back Next >>

Rev Invest Clin 2017; 69 (6)

Abnormal Cardiovascular Findings in Acute Pancreatitis: Are They Associated with Disease Severity?

Chacón-Portillo MA, Payró-Ramírez G, Peláez-Luna MC, Uscanga-Domínguez LF, Vasquéz-Ortiz Z, Orihuela C, Martínez-Vázquez SE, Hernández-Calleros J

Language: English
References: 22
Page: 314-318
PDF size: 70.80 Kb.


ABSTRACT

Background: Acute pancreatitis (AP), a disease that commonly requires in-hospital treatment, has been associated with a high incidence of abnormal cardiovascular findings (ACFs). We conducted a prospective study to explore the association of these findings with severity of the disease. Methods: Adult patients with AP diagnosis were prospectively enrolled in an observational study during an 8-month period in a tertiary care center. AP and its severity were defined according to the Revised Atlanta Classification of AP. Subjects were submitted to electrocardiographic, echocardiographic, and serologic testing during the acute period and a 3-month follow-up. The incidence of ACF was compared between two groups: (1) Mild and (2) moderate/severe cases. Results: Twenty-seven patients (mean age 48 ± 17 years) with AP were enrolled; 15 (55%) had mild and 12 (45%) had moderate/severe AP. During the acute episode, 67% had increased pro-brain natriuretic peptide levels; 52% had abnormal electrocardiographic findings; 48% had abnormal echocardiographic findings; and 18% had increased troponin I levels. There was no significant difference in the incidence of ACF between mild and moderate/severe groups. Nineteen patients (70%) had repeated follow-up testing, and most of the initial ACF did not persist. Conclusion: ACFs occur in an important proportion of patients during AP episodes. Future research should continue to focus in the association of ACFs and the severity of the disease.


REFERENCES

  1. Agarwal S, George J, Padhan RK, et al. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years. Pancreatology. 2016;16:194-9.

  2. Drummond J. Cardiac abnormalities of abdominal origin. S Afr Med J. 1934;8:520-6.

  3. Rubio-Tapia A, García-Leiva J, Asensio-Lafuente E, Robles-Díaz G, Vargas-Vorácková F. Electrocardiographic abnormalities in patients with acute pancreatitis. J Clin Gastroenterol. 2005; 39:815-8.

  4. Yegneswaran B, Kostis JB, Pitchumoni CS. Cardiovascular manifestations of acute pancreatitis. J Crit Care. 2011;26:225. e11-8.

  5. Bugdaci MS, Oztekin E, Kara E, Koker I, Tufan A. Prognostic value of increased B type natriuretic peptide in cases with acute pancreatitis. Eur J Intern Med. 2012;23:e97-e100.

  6. Pezzilli R, Barassi A, Iammarino MT, d’Eril GM. Is troponin T a useful marker of myocardial damage in acute pancreatitis? A prospective time course study. Dig Liver Dis. 2013;45:347-8.

  7. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl. 1999;230:132-42.

  8. Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure-different proBNP-108 to BNP-32 ratios in atrial and ventricular overload. Heart. 2010;96:432-9.

  9. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197-204.

  10. Saulea A, Costin S, Rotari V. Heart ultrastructure in experimental acute pancreatitis. Rom J Physiol. 1997;34:35-44.

  11. Albrecht CA, Laws FA. ST segment elevation pattern of acute myocardial infarction induced by acute pancreatitis. Cardiol Rev. 2003;11:147-51.

  12. Khairy P, Marsolais P. Pancreatitis with electrocardiographic changes mimicking acute myocardial infarction. Can J Gastroenterol. 2001;15:522-6.

  13. Nadkarni N, Bhasin DK, Rana SS, et al. Diastolic dysfunction, prolonged QTc interval and pericardial effusion as predictors of mortality in acute pancreatitis. J Gastroenterol Hepatol. 2012;27:1576-80.

  14. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62: 102-11.

  15. Talukdar R, Bhattacharrya A, Rao B, Sharma M, Reddy DN. Clinical utility of the revised Atlanta classification of acute pancreatitis in a prospective cohort: Have all loose ends been tied? Pancreatology. 2014;14:257-62.

  16. Talukdar R, Clemens M, Vege SS. Moderately severe acute pancreatitis: Prospective validation of this new subgroup of acute pancreatitis. Pancreas. 2012;41:306-9.

  17. Vege SS, Gardner TB, Chari ST, et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: A case for revising the Atlanta classification to include “moderately severe acute pancreatitis”. Am J Gastroenterol. 2009; 104:710-5.

  18. Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012; 142:1476-82.

  19. Forsmark CE, Baillie J, Practice AG, Economics C, Board AG. AGA institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022-44.

  20. Aundhakar S, Mahajan S, Agarwal A, Mhaskar D. Acute pancreatitis associated with elevated troponin levels: Whether to thrombolyse or not? Ann Med Health Sci Res. 2013; 3 Suppl 1:S50-2.

  21. Dettori JR. Loss to follow-up. Evid Based Spine Care J. 2011; 2:7-10.

  22. Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: How much is too much? Eur J Epidemiol. 2004;19:751-60.




2020     |     www.medigraphic.com